Table 7. Supplementary Table 6: Neurological adverse drug events suspected to be caused by unknown vaccine use in COVID-19.
Broad heading | Specific adverse event | Non-serious n (%) (n=39) | Serious n (%) (n=16) | Total n(%) (n=55) |
Nervous System Disorder(n=55) | Balance disorder | 0(0.00) | 1(6.25) | 1(1.82) |
Cerebrovascular accident | 0(0.00) | 1(6.25) | 1(1.82) | |
Dizziness | 5(12.82) | 2(12.5) | 7(12.73) | |
Dysgeusia | 1(2.56) | 1(6.25) | 2(3.64) | |
Dysstasia | 0(0.00) | 1(6.25) | 1(1.82) | |
Headache | 22(56.41) | 4(25.0) | 26(47.27) | |
Hypoaesthesia | 1(2.56) | 0(0.00) | 1(1.82) | |
Lethargy | 1(2.56) | 1(6.25) | 2(3.64) | |
Migraine | 1(2.56) | 1(6.25) | 2(3.64) | |
Paraesthesia | 1(2.56) | 0(0.00) | 3(5.45) | |
Presyncope | 1(2.56) | 1(6.25) | 2(3.64) | |
Sinus headache | 1(2.56) | 0(0.00) | 1(1.82) | |
Syncope | 1(2.56) | 1(6.25) | 2(3.64) | |
Taste disorder | 1(2.56) | 0(0.00) | 1(1.82) | |
Transient ischaemic attack | 0(0.00) | 1(6.25) | 1(1.82) | |
Tremor | 1(2.56) | 1(6.25) | 2(3.64) |